findmyKOL

Anjail Sharrief, MD

Enriched profile

Professor of Neurology and Director of Stroke Prevention, UTHealth Institute for Stroke and Cerebrovascular Disease · McGovern Medical School at UTHealth Houston

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Houston, TX · South Central · United StatesSpecialtyNeurologyFocusAcute Ischemic Stroke Management+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2021–2026

Anjail Sharrief is Professor of Neurology and Director of Stroke Prevention, UTHealth Institute for Stroke and Cerebrovascular Disease at McGovern Medical School at UTHealth Houston. OpenAlex indexes 196 publications with 6,765 citations (h-index 24); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 11 Oct 2026

Overview

Updated 13 Oct 2026

Anjail Sharrief, MD, is Professor of Neurology and Director of Stroke Prevention, UTHealth Institute for Stroke and Cerebrovascular Disease at McGovern Medical School at UTHealth Houston. The public record shows 196 publications with 6,765 citations (h-index 24), centered on Acute Ischemic Stroke Management, Stroke Rehabilitation and Recovery, Intracerebral and Subarachnoid Hemorrhage Research. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 20 companies, 2 NIH-funded awards (2021–2026).

  • Most recent indexed publication: 2026 · Stroke
  • Top research focus: Acute Ischemic Stroke Management
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Stroke2 trialsHypertension

Research focus

OpenAlex concept fingerprint
Acute Ischemic Stroke ManagementStroke Rehabilitation and RecoveryIntracerebral and Subarachnoid Hemorrhage ResearchTelemedicine and Telehealth ImplementationBlood Pressure and Hypertension Studies

Drugs & molecules

across trials, industry payments and publications
Xareltogeneric · RivaroxabanClinical trials—Industry payments9Publications1Eliquisgeneric · ApixabanClinical trials—Industry payments3Publications1Ultomirisgeneric · RavulizumabClinical trials—Industry payments4Publications—Ozempicgeneric · SemaglutideClinical trials—Industry payments3Publications—Repathageneric · EvolocumabClinical trials—Industry payments2Publications—Vyalevgeneric · Carbidopa / levodopaClinical trials—Industry payments2Publications—Ajovygeneric · FremanezumabClinical trials—Industry payments1Publications—DeutetrabenazineClinical trials—Industry payments1Publications—Fabrazymegeneric · Agalsidase betaClinical trials—Industry payments1Publications—Inbrijageneric · LevodopaClinical trials—Industry payments1Publications—Invokanageneric · CanagliflozinClinical trials—Industry payments1Publications—Quliptageneric · AtogepantClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Medtronic, Inc.Clinical trials—Industry payments15Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments7Novo Nordisk IncClinical trials—Industry payments7Abbott LaboratoriesClinical trials—Industry payments6Janssen Pharmaceuticals, IncClinical trials—Industry payments5Janssen Scientific Affairs, LLCClinical trials—Industry payments5AstraZeneca Pharmaceuticals LPClinical trials—Industry payments4Genzyme CorporationClinical trials—Industry payments4Abbvie Inc.Clinical trials—Industry payments3Amgen Inc.Clinical trials—Industry payments3Inspire Medical Systems, Inc.Clinical trials—Industry payments3Pfizer Inc.Clinical trials—Industry payments3Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments2The University of Texas Health Science Center, HoustonClinical trials2Industry payments—Acorda Therapeutics, IncClinical trials—Industry payments1Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments1C2N Diagnostics, LLCClinical trials—Industry payments1Kyowa Kirin, Inc.Clinical trials—Industry payments1Microtransponder, Inc.Clinical trials—Industry payments1Neurocrine BioSciences, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
196publications

Distinct works indexed by OpenAlex, matched via ORCID; 13 in PubMed.

6,765citations

Total citations across indexed works.

24h-index

Hirsch index (OpenAlex). i10-index 45.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2021–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 13 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Oct 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    58.1%
    Statin26.9%
    Atorvastatin Calcium84%Rosuvastatin Calcium17%
    Part D<11 patients
    Calcium channel blocker8.1%
    Nifedipine Er60%Amlodipine Besylate41%
    Part D<11 patients

    + 5 more classes in this area

  • Nervous system

    28.7%
    Other antiepileptics9.5%
    Levetiracetam61%Topiramate39%
    Part D<11 patients
    SSRI5.4%
    Sertraline Hcl54%Escitalopram Oxalate46%
    Part D<11 patients

    + 4 more classes in this area

  • Blood & clotting

    8.7%
    Factor Xa inhibitor5.6%
    Eliquis100%
    Part D<11 patients
    P2Y12 inhibitor3.1%
    Clopidogrel100%
    Part D<11 patients
All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)32.9% facility · 67.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 13 Oct 2026

2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:

Publications

Updated 13 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 13 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Sean Isaac Savitz80Munachi N. Okpala45Jennifer E. S. Beauchamp25Farhaan Vahidy22Mary Carter Denny21Erica Jones19Nicole R. Gonzales16Lauren E Fournier14Mary F. Love14Kim Yen Thi Vu14Tahani Casameni Montiel13James C. Grotta13Louise D. McCullough13Amrou Sarraj13Chunyan C. Cai12Audrey Sarah Cohen12José‐Miguel Yamal12Evelyn Hinojosa11Maha Almohamad11Mengxi Wang11Andrew D. Barreto10Imama Ali Naqvi9Chigozirim Izeogu9Andrea Ancer Leal9Gabretta Cooksey9Tzu‐Ching Wu9Nnedinma Okpala8Christy M. Ankrom8Kristin Brown8Alicia M. Zha7Ritvij Bowry7Amanda L Jagolino-Cole7Thanh N. Nguyen7Hari Kishan Reddy Indupuru7Deepa Dongarwar7Deep Kiritbhai Pujara6Kaushik Parsha6Nneka L. Ifejika6James Ernest Siegler6Lesli E. Skolarus6

Online presence

Updated 13 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/anjail-sharrief-ibrahim-md-mph-a54564a3

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • Doximity

    doximity.com/pub/anjail-sharrief-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Apple Podcasts

    podcasts.apple.com/us/podcast/stroke-busters/id1542996784

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 13 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Columbia University College of Physicians and Surgeons

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
  • Board certified in Neurology

    American Board of Psychiatry and Neurology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗

Editorial & leadership roles

journal and society appointments
  • Vice Chair

    American Heart Association/American Stroke Association Guideline for the Primary Prevention of Stroke

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
  • Fellow

    American Heart Association (FAHA)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗

Secondary affiliations

appointments beyond the home institution
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.uth.edu ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.